Skip to main content

Co-Diagnostics, Inc.

CODX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001692415

No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +10 vs. previous quarter
24
13F valueReported value at the end of Q2 2026
$1.85M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding CODX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding CODX at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Co-Diagnostics, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 21, 2023 (view filing)Mar 201 dayBrown Brian LeeChief Financial OfficerPPurchase+3.00K$1.90+$5.70K+4.1%76.2K after
Sep 22, 2021 (view filing)Sep 814 daysLateDurenard EugeneDirectorSSale−2.00K$10.46−$20.9K−100.0%0 after

Top 10 13F holders, Q2 2026

The largest institutional positions in Co-Diagnostics, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 24 holders
Institutions holding CODX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC236,000$731.6K0.02%+236,000New
Jane Street Group, LLC89,240$276.6K0.00%+89,240New
Vanguard Capital Management LLC58,275$180.7K0.00%+58,275New
Private Advisory Group LLC39,387$122.1K0.01%−2,000−4.8%Reduced
Millennium Management LLC31,995$99.2K0.00%+31,995New
Susquehanna International Group, LLP31,239$96.8K0.00%+31,239New
Geode Capital Management, LLC25,575$79.3K0.00%+25,575New
Vanguard Fiduciary Trust Co19,776$61.3K0.00%+19,775+1,977,500.0%Added
Virtu Financial LLC17,612$55.0K0.00%+17,612New
UBS Group AG16,091$49.9K0.00%+8,723+118.4%Added